Clinical Trial Update: Ziconotide as First-Line IDT [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating ziconotide as first-line intrathecal therapy for neuropathic pain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuropathic Pain

Drugs mentioned

• Ziconotide (ziconotide)

Snippet

Sponsor: Albany Medical College | Conditions: Neuropathic Pain | Phase 4 | Status: COMPLETED